Skip to the main content.
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Studying Bacterial Biofilm Formation and Stress Responses Using the BioFlux Microfluidic Platform

Speaker: Dr. Mark Webber, PhD, Quadram Institute

Dr. Mark Webber is a Group Leader at the Quadram institute and studies antimicrobial resistance. In this webinar, Dr. Webber will describe his work in biofilms, antimicrobial resistance and his use of the BioFlux System.